# TruGraf Utilization in High IPV Levels

> **NCT04280276** · NA · TERMINATED · sponsor: **University of Maryland, Baltimore** · enrollment: 13 (actual)

## Conditions studied

- Kidney Transplant; Complications

## Interventions

- **DIAGNOSTIC_TEST:** TruGraf test

## Key facts

- **NCT ID:** NCT04280276
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-03-02
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-03-01
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Sponsor, TGI, was acquired by Eurofins Inc. New owner requested all IIT's be terminated.
- **Last updated:** 2024-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04280276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04280276, "TruGraf Utilization in High IPV Levels". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04280276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*